A Study of Pioglitazone and Carboplatin in Patients With Advanced Solid Tumors
Status:
Completed
Trial end date:
2016-01-01
Target enrollment:
Participant gender:
Summary
The proposed investigation is a Phase 1 trial to determine the safety, tolerability, and
maximum tolerated dose (MTD) of the combination of pioglitazone ( and carboplatin patients
with advanced or metastatic solid malignancies.